Literature DB >> 16332954

Methotrexate induced pancytopenia is rare and concern for it should not limit its use.

Y Yazici.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16332954     DOI： 10.1093/rheumatology/kei199

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

1.  Metabolism and disposition of a novel antineoplastic JS-38 (Benzamide, N-[4-(2,4-dimethoxyphenyl)-4,5-dihydro-5-oxo-1,2-dithiolo[4,3-b]pyrrol-6-yl]-3,5-bis (trifluoromethyl)-(9Cl)) in rats.

Authors:  Hong Zhang; Quanhai Liu; Tingting Fan; Yu Fang; Ying Li; Guoping Wang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-07-30       Impact factor: 2.441

2.  The pharmacokinetics of JS-38, a novel antineoplastic drug, in rats.

Authors:  Hong Zha Ng; Yu Fang; Ying Li; Ting-Ting Fan; Yan Qin; Quan-Hai Liu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jul-Sep       Impact factor: 2.441

3.  Pott's disease and hypercalcemia in a patient with rheumatoid arthritis receiving methotrexate monotherapy.

Authors:  Mehmet Zorlu; Muharrem Kiskac; Cumali Karatoprak; Mustafa Cakirca; Erdinç Yavuz; Güven Cetin; Mehmet Ali Cıkrıkçıoğlu
Journal:  Indian J Pharmacol       Date:  2013 Nov-Dec       Impact factor: 1.200

4.  Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.

Authors:  Shunsuke Mori; Michihiro Hidaka; Toshiro Kawakita; Toshihiko Hidaka; Hiroyuki Tsuda; Tamami Yoshitama; Kiyoshi Migita; Yukitaka Ueki
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.